Related Experiment Videos
[Virus-like particles as a source for obtaining antigens for diagnosing rubella]
Voprosy Virusologii
|March 10, 2001
Summary
Rubella virus-like particles (RVLP) offer a stable, easily purified antigen for developing diagnostic tests. These RVLP-based rubella diagnostics show comparable performance to traditional methods.
Area of Science:
- Virology
- Immunology
- Biotechnology
Context:
- Rubella diagnostics traditionally rely on native virus antigens, which can be challenging to produce and purify.
- Development of non-infectious, recombinant viral antigens offers a safer and potentially more scalable alternative.
Purpose:
- To develop and characterize rubella virus-like particles (RVLP) as antigens for diagnostic assays.
- To evaluate the immunogenicity and diagnostic performance of RVLP-based antigens for rubella detection.
Summary:
- Non-infectious rubella virus-like particles (RVLP), expressing E1, E2, and C proteins, were produced in CHO24S cell culture.
- RVLP antigens demonstrated high hemagglutination inhibition (HI) titers (1:256), significantly enhanced by Tween-80 and ether treatment, improving stability.
- RVLP immunogenicity matched native rubella virus in HI tests and mouse immunization studies. EIA antigens derived from RVLP showed comparable results to native virus antigens in human serum testing.
Impact:
- RVLP provide a stable, antigenically identical, and easily purified alternative to native rubella virus for commercial diagnostic antigen production.
- This advancement can lead to more accessible and reliable rubella diagnostic kits.
- Facilitates improved rubella surveillance and control strategies.